Skip to Main Content

Author Details

Alastair Davies
University of British Columbia
2008
24
19
PMIDPaper TitleJournal TitlePublished Year
37470668The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity.Cancer Discov2023
35477723ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.Nat Commun2022
34128829Targeting androgen receptor signaling: a historical perspective.Endocr Relat Cancer2021
33741908CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.Nat Commun2021
33758253Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer.Sci Rep2021
34489572An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.Nat Cell Biol2021
31917811Complex patterns of cell growth in the placenta in normal pregnancy and as adaptations to maternal diet restriction.PLoS One2020
31804971The epigenetic and transcriptional landscape of neuroendocrine prostate cancer.Endocr Relat Cancer2020
30772358Biological Evolution of Castration-resistant Prostate Cancer.Eur Urol Focus2019
29460922Cellular plasticity and the neuroendocrine phenotype in prostate cancer.Nat Rev Urol2018
28315377Patient-derived xenografts: A platform for accelerating translational research in prostate cancer.Mol Cell Endocrinol2018
27784708The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.Cancer Discov2017
28899970Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition.Clin Cancer Res2017
26880966The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem Cells.Stem Cells Int2016
25934687Regulation of tumor cell plasticity by the androgen receptor in prostate cancer.Endocr Relat Cancer2015
26011941Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells.Oncotarget2015
24648416YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.Stem Cells2014
21423216YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification.Oncogene2011
21576761YB-1 drives preneoplastic progression: Insight into opportunities for cancer prevention.Oncotarget2011
20332234Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.Cancer Res2010
19151767Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells.Oncogene2009
19887553Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.Mol Cancer Ther2009
18662396Spatial and temporal expression of the 23 murine Prolactin/Placental Lactogen-related genes is not associated with their position in the locus.BMC Genomics2008
19036157Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.Breast Cancer Res2008
  • 1 - 24 of 24

Recommended Authors

Fred Hutchinson Cancer Research Center
Career Start Year 2015
Number of shared co-authors 0
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 5
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 17
Oncology R&D
Career Start Year 2013
Number of shared co-authors 4
University of British Columbia
Career Start Year 2012
Number of shared co-authors 18
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 9
Sandra and Edward Meyer Cancer Center
Career Start Year 2010
Number of shared co-authors 18
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 8
University of British Columbia
Career Start Year 2008
Number of shared co-authors 15
Northwestern University Feinberg School of Medicine Chicago
Career Start Year 2008
Number of shared co-authors 4
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 2007
Number of shared co-authors 18
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year 2006
Number of shared co-authors 11
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 16
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 6
University of Cambridge
Career Start Year 2003
Number of shared co-authors 5
The Institute for Cancer Research
Career Start Year 2003
Number of shared co-authors 9
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2002
Number of shared co-authors 19
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 4
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 10
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 5
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 19
Research Institute of the McGill University Health Centre
Career Start Year 2000
Number of shared co-authors 4
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 6
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 17
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 5
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 8
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 17
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 19
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 14

Collaborators

University of British Columbia
Co-authored papers 14
Dana-Farber Cancer Institute
Co-authored papers 5
Adelaide Medical School, University of Adelaide
Co-authored papers 3
University of British Columbia
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
University of Calgary
Co-authored papers 2
UCSF Medical Center-Mount Zion
Co-authored papers 2
University of British Columbia
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 2
University of British Columbia
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
School of Public Health, Sun Yat-sen University
Co-authored papers 1
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 1
University of British Columbia
Co-authored papers 1
University of Toronto
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Center for Epigenetics, Van Andel Research Institute
Co-authored papers 1
Princess Margaret Cancer Research Centre
Co-authored papers 1
University of Bern
Co-authored papers 1
University of California los angeles
Co-authored papers 1
College of Life Science, Hunan Normal University
Co-authored papers 1
Princess Margaret Cancer Center/University Health Network
Co-authored papers 1
University of British Columbia
Co-authored papers 1
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
University of British Columbia
Co-authored papers 1
University of Oulu
Co-authored papers 1
University of Toronto
Co-authored papers 1
Seattle Children's Research Institute
Co-authored papers 1